Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis

• Main Authors: Chee Khoon Lee, Chris Brown, Richard J. Gralla, Vera Hirsh, Sumitra Thongprasert, Chun Ming Tsai, Eng Huat Tan, James Chung Man Ho, Da Tong Chu, Adel Zaatar, Jemela Anne Osorio Sanchez, Vu Van Vu, Joseph Siu Kie Au, Akira Inoue, Siow Ming Lee, Val Gebski, James Chih Hsin Yang
• Format: Journal
• Published: 2018
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877291745&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/47986
• Institution: Chiang Mai University

Background The epidermal growth factor receptor (EGFR) signaling pathway is crucial for regulating tumorigenesis and cell survival and may be important in the development and progression of non-small cell lung cancer (NSCLC). We examined the impact of EGFR-tyrosine kinase inhibitors (TKIs) on progre...